Granulocyte-macrophage colony-stimulating factor inhalation therapy for patients with idiopathic pulmonary alveolar proteinosis: A pilot study; and long-term treatment with aerosolized granulocyte-macrophage colony-stimulating factor: A case report

Respirology

Volumn 11, Issue SUPPL. 1, 2006, Pages

  Tazawa, Ryushi ^a   Nakata, Koh ^b   Inoue, Yoshikazu ^c   Nukiwa, Toshihiro ^a  

^a TOHOKU UNIVERSITY HOSPITAL   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KINKI CHUO CHEST MEDICAL CENTER   (Japan)

Author keywords

Aerosols; Autoantibodies; Granulocyte macrophage colony stimulating factor; Inhalation; Pulmonary alveolar proteinosis

Indexed keywords

RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; CASE REPORT; CELL DIFFERENTIATION; CONFERENCE PAPER; FEMALE; HUMAN; IDIOPATHIC PULMONARY ALVEOLAR PROTEINOSIS; LIPOPHILICITY; LUNG ALVEOLUS; LUNG ALVEOLUS PROTEINOSIS; MACROPHAGE; MALE; NEBULIZATION; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SURFACE PROPERTY;

AEROSOLS; AUTOANTIBODIES; BRONCHOALVEOLAR LAVAGE FLUID; DRUG ADMINISTRATION SCHEDULE; DRUG COMPOUNDING; FEMALE; GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTORS, RECOMBINANT; HUMANS; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PILOT PROJECTS; PULMONARY ALVEOLAR PROTEINOSIS; RECURRENCE; RESPIRATORY THERAPY;

EID: 33645104223     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2006.00811.x     Document Type: Conference Paper

References (14)

1. Seymour JF Presneill JJ Pulmonary alveolar proteinosis: progress in the first 44 years AmJRespirCritCare Med 2002 166 215 35
2. Trapnell BC Whitsett JA Nakata K Pulmonary Alveolar Proteinosis NEnglJMed 2003 349 2527 39
3. Kitamura T Tanaka N Watanabe J et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor JExpMed 1999 190 875 80
4. Seymour JF Presneill JJ Schoch OD et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis AmJRespirCritCare Med 2001 163 524 31
5. Kavuru MS Sullivan EJ Piccin R Thomassen MJ Stoller JK Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis AmJRespirCritCare Med 2000 161 1143 8
6. Schoch OD Schanz U Koller M et al. BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF Thorax 2002 57 277 80
7. Wylam MERM Katzmann JA Clawson M Prakash UBS Anderson PM Aerosolized GM-CSF improves pulmonary function in idiopathic pulmonary alveolar proteinosis [abstract] AmJRespirCritCare Med 2000 161 A889
8. Reed JA Ikegami M Cianciolo ER et al. Aerosolized GM-CSF ameliorates pulmonary alveolar proteinosis in GM-CSF deficient mice AmJPhysiol 1999 276 L556 63
9. Niven RW Delivery of biotherapeutics by inhalation aerosol CritRevTherDrug Carrier Syst 1995 12 151 231
10. Wolff RK Safety of inhaled proteins for therapeutic use JAerosol Med 1998 11 197 219
11. Arai T Hamano E Inoue Y et al. Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF RespirMed 2004 98 1227 30
12. Tazawa R Hamano E Arai T et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis AmJRespirCritCare Med 2005 171 1142 9
13. Uchida K Nakata K Trapnell BC et al. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis Blood 2004 103 1089 98
14. Leung K Louca E Coates AL Comparison of breath-enhanced to breath-actuated nebulizers for rate, consistency, and efficiency Chest 2004 126 1619 27